Search results
Results from the WOW.Com Content Network
Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous system to machines. “We've got ...
Neuralink's study is estimated to have a primary completion date of 2026, with the full study expected to be complete in 2031. The study will enroll patients between the ages of 22 and 75 years ...
Neuralink provided a few details in February on the implant in a recruitment brochure for the Precise Robotically Implanted Brain-Computer Interface (PRIME) study. [96] On February 20, Musk said that Neuralink's first human trial participant had been able to control a computer mouse by thought.
The study uses a robot to surgically place a brain-computer interface implant in a region of the brain that controls the intention to move, Neuralink has said, adding that the initial goal is to ...
The trial, called CAN-PRIME, has started recruiting patients for a study that will test the safety and efficacy of a device that allows people to move cursors with their minds, a surgeon leading ...
Elon Reeve Musk (/ ˈ iː l ɒ n m ʌ s k /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. He is also known for his ownership of X Corp. (the company that operates the social media platform X, formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
This trial is expected to enroll three patients to evaluate its device in a study expected to take several years to complete, according to details on the U.S. government's clinical trials database.
Blindsight is being developed to enable individuals with total visual impairment due to damage to the optic nerve but with intact visual cortex to see, this is made possible by bypassing the optic nerve and directly stimulating the visual cortex to create a visual perception.